Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Jul 10, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$15.3B
sum of reported positions
Reported positions
219
Changes vs prior quarter
213
25 new · 19 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 263 measured positions in 8 quarters, the typical new or larger position finished −6.6 pts against the S&P 500 and 35% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 7.96M | $719M | 4.7% | |
| 2.28M | $365M | 2.4% | |
| 2.12M | $346M | 2.3% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $15.1B | $15.3B |
| Positions | 213 | 219 |
| Biggest line | — | HealthEquity 5% |
| 3.53M |
| $342M |
| 2.2% |
| 637K | $337M | 2.2% |
| 4.36M | $335M | 2.2% |
| 846K | $303M | 2.0% |
| 2.34M | $297M | 1.9% |
| 8.28M | $287M | 1.9% |
| 513K | $278M | 1.8% |
| 869K | $273M | 1.8% |
| 3.24M | $261M | 1.7% |
| 2.87M | $261M | 1.7% |
| 4.7M | $245M | 1.6% |
| 2.75M | $242M | 1.6% |
| 6.07M | $240M | 1.6% |
| 3.6M | $235M | 1.5% |
| 1.48M | $223M | 1.5% |
| 1.59M | $217M | 1.4% |
| 3.63M | $214M | 1.4% |
| 3.25M | $212M | 1.4% |
| 322K | $207M | 1.4% |
| 121K | $205M | 1.3% |
| 1.2M | $199M | 1.3% |
| 693K | $193M | 1.3% |
Mama'S Creations (MAMA)
2.08M → 1.81M shares (−13%)
Del Monte Corporation (DMC)
1.38M → 1.16M shares (−16%)
Atlas Energy Solutions, Inc. (AESI)
1.83M shares
Limbach Holdings (LMB)
970K → 381K shares (−61%)
Certara, Inc. (CERT)
5.27M → 4.3M shares (−19%)
Lincoln Educational Services (LINC)
777K → 548K shares (−30%)
Digi International Inc. (DGII)
450K → 353K shares (−22%)
Netskope (NTSK)
2.29M shares
Elmet Group (ELMT)
1.22M shares
American Integrity Insurance Group (AII)
1.19M → 1.26M shares (+6%)
Tarsus Pharmaceuticals (TARS)
369K shares
Willdan Group (WLDN)
382K → 287K shares (−25%)
TransMedics Group, Inc. (TMDX)
346K → 308K shares (−11%)
Journey Medical (DERM)
2.13M → 2.86M shares (+34%)
EZCORP, Inc. (EZPW)
714K → 548K shares (−23%)
Shake Shack, Inc. (SHAK)
407K → 319K shares (−22%)
Indie Semiconductor (INDI)
3.81M → 3.76M shares (−1%)
C4 Therapeutics (CCCC)
2.96M → 3.52M shares (+19%)
Latham Group (SWIM)
2.57M → 2.52M shares (−2%)
Climb Global Solutions (CLMB)
608K → 691K shares (+14%)
A10 Networks, Inc. (ATEN)
416K shares
OPEN LENDING CORP
7.05M → 4.87M shares (−31%)
Phathom Pharmaceuticals (PHAT)
1.34M → 1.31M shares (−3%)
LGI Homes (LGIH)
184K → 213K shares (+16%)
Suja Life (SUJA)
1.33M shares
